Compare MAN & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MAN | PLSE |
|---|---|---|
| Founded | 1948 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 1994 | 2015 |
| Metric | MAN | PLSE |
|---|---|---|
| Price | $30.40 | $22.88 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $35.67 | $22.00 |
| AVG Volume (30 Days) | ★ 1.2M | 229.2K |
| Earning Date | 04-16-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.89% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $17,957,100,000.00 | N/A |
| Revenue This Year | $5.12 | $840.00 |
| Revenue Next Year | $3.42 | $287.54 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.58 | N/A |
| 52 Week Low | $25.15 | $12.56 |
| 52 Week High | $47.34 | $26.30 |
| Indicator | MAN | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 54.35 | 56.01 |
| Support Level | $28.76 | $17.32 |
| Resistance Level | $30.40 | $23.42 |
| Average True Range (ATR) | 1.91 | 1.34 |
| MACD | 0.02 | 0.25 |
| Stochastic Oscillator | 60.43 | 72.50 |
ManpowerGroup Inc provides workforce solutions and services, including recruitment and assessment, upskilling, reskilling, training and development, career management, outsourcing, and workforce consulting. The company leverages its trusted brands, industry knowledge, and AI-enabled assessments and offers an extensive portfolio of training and leadership development solutions. Its reportable segments are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others, with Staffing and Interim generating the majority of revenue. It operates in the Americas, Southern Europe, Northern Europe, and APME. The company derives the maximum geographical revenue from the Southern European region.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.